Research Field:
Evolutionary toxicology (eTOX)-based conceptual framework to understand the mechanisms of cancer development and metabolic diseases
Identification and validation of first-in-class drug targets for cancer and metabolic diseases
Characterizing and targeting both cancer-type specific metabolic pathways and tumor microenvironment based on evolutionary toxicology (eTOX).
Development of eTOX-based metabolism assay and screening platforms for drug discovery